论文部分内容阅读
德国一家公司研制出一种新型抗丙肝药物,能抑制病毒在人体内的复制。这种名为BILN2061的新药能够抑制丙肝病毒复制所必需的一种酶。在试验中,8名丙肝患者服用
A German company has developed a new anti-hepatitis C drug that inhibits the replication of the virus in the human body. This new drug called BILN2061 can inhibit an enzyme necessary for the replication of hepatitis C virus. In the trial, 8 patients with hepatitis C were taken